Research Output per year
Publications 1995 2019
- 1 - 50 out of 146 results
- Publication Year, Title (descending)
2019
Dasatinib and navitoclax act synergistically to target NUP98-NSD1(+)/FLT3-ITD+ acute myeloid leukemia
Kivioja, J. L., Thanasopoulou, A., Kumar, A., Kontro, M., Yadav, B., Majumder, M. M., Javarappa, K. K., Eldfors, S., Schwaller, J., Porkka, K. & Heckman, C. A., Jun 2019, In : Leukemia. 33, 6, p. 1360-1372 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML
Karjalainen, R., Liu, M., Kumar, A., Malani, D., Parsons, A. O., Kontro, M., Kallioniemi, O., Porkka, K. & Heckman, C., 2019, In : Leukemia.Research output: Contribution to journal › Letter › Scientific › peer-review
Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies
Pölönen, P., Mehtonen, J., Lin, J., Liuksiala, T., Häyrynen, S., Teppo, S., Mäkinen, A., Kumar, A., Malani, D., Pohjolainen, V., Porkka, K., Heckman, C. A., May, P., Hautamäki, V., Granberg, K. J., Lohi, O., Nykter, M. & Heinäniemi, M., 15 May 2019, In : Cancer Research. 79, 10, p. 2466-2479 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
Hohtari, H., Bruck, O., Blom, S., Turkki, R., Sinisalo, M., Kovanen, P. E., Kallioniemi, O., Pellinen, T., Porkka, K. & Mustjoki, S., Jul 2019, In : Leukemia. 33, 7, p. 1570-1582 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematological cells that are retained in corresponding malignant cell types
Majumder, M. M., Leppä, A-M., Hellesøy, M., Dowling, P., Malyutina, A., Kopperud, R., Bazou, D., Andersson, E., Parsons, A., Tang, J., Kallioniemi, O., Mustjoki, S., O'Gorman, P., Wennerberg, K., Porkka, K., Gjertsen, B. T. & Heckman, C. A., 22 Aug 2019, In : Haematologica. p. haematol.2019.217414Research output: Contribution to journal › Article › Scientific › peer-review
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
Kuusanmäki, H., Leppä, A-M., Pölönen, P., Kontro, M., Dufva, O., Deb, D., Yadav, B., Bruck, O., Kumar, A., Everaus, H., Gjertsen, B. T., Heinäniemi, M., Porkka, K., Mustjoki, S. & Heckman, C., 11 Jul 2019, In : Haematologica.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
2018
Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia
Ojamies, P. N., Kontro, M., Edgren, H., Ellonen, P., Heckman, C., Porkka, K., Wolf, M. & Kallioniemi, O., 2 Dec 2018, In : Leukemia & lymphoma. 59, 12, p. 3002-3005 4 p.Research output: Contribution to journal › Letter › Scientific › peer-review
Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia
Kivioja, J., Lopez Marti, J. M., Kumar, A., Kontro, M., Edgren, H., Parsons, A., Lundan, T., Wolf, M., Porkka, K. & Heckman, C., 2018, In : Leukemia & lymphoma. 59, 3, p. 725-732 8 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Combined Targeting of BET Family Proteins and BCL2 Is Synergistic in Acute Myeloid Leukemia Cells Overexpressing S100A8 and S100A9
Karjalainen, R., Liu, M., Kumar, A., Parsons, A., He, L., Malani, D. R., Kontro, M., Porkka, K. & Heckman, C. A., 2018, In : Blood. 132Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Open Access
Germline alterations in a consecutive series of acute myeloid leukemia
Wartiovaara-Kautto, U., Hirvonen, E. A. M., Pitkänen, E., Heckman, C., Saarela, J., Kettunen, K., Porkka, K. & Kilpivaara, O., Oct 2018, In : Leukemia. 32, 10, p. 2282-2285 4 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
Bruck, O., Blom, S., Dufva, O., Turkki, R., Chheda, H., Ribeiro, A., Kovanen, P., Aittokallio, T., Koskenvesa, P., Kallioniemi, O., Porkka, K., Pellinen, T. & Mustjoki, S., Jul 2018, In : Leukemia. 32, 7, p. 1643-1656 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Multi-Parametric Single Cell Profiling Defines Distinct Drug Responses in Healthy Hematological Cell Lineages That Are Retained in Corresponding Malignant Cell Types
Majumder, MM., Leppä, A-M., Hellesøy, M., Dowling, P., Malyutina, A., Bazou, D., Andersson, E. I., Parsons, A., Tang, J., Kallioniemi, O-P., Mustjoki, S. M., O'Gorman, P., Wennerberg, J. K., Porkka, K. V. K., Gjertsen, B-T. & Heckman, C. A., 2018, In : Blood. 132Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Open Access
Syövän immunologinen täsmähoito geneettisesti muokatuilla T-soluilla
Korhonen, M., Keränen, M., Vettenranta, K., Leppä, S., Ylä-Herttuala, S. & Porkka, K., 2018, In : Duodecim. 134, 16, p. 1592-1599 8 p.Research output: Contribution to journal › Review Article › Scientific › peer-review
Open Access
File
Targeting BCL-2, BCL-XL, BCL-W and MDM2 in B-Cell Acute Lymphoblastic Leukemia Is Highly Effective Ex Vivo
Hohtari, H., Adnan Awad, S., Dufva, O., Potdar, S., Heckman, C., Wennerberg, K., Mustjoki, S. & Porkka, K., 2018.Research output: Conference materials › Abstract › Research › peer-review
Open Access
2017
Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models
Hekim, C., Ilander, M., Yan, J., Michaud, E., Smykla, R., Vaha-Koskela, M., Savola, P., Tahtinen, S., Saikko, L., Hemminki, A., Kovanen, P. E., Porkka, K., Lee, F. Y. F. & Mustjoki, S., Feb 2017, In : Cancer immunology research. 5, 2, p. 157-169 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
Pietarinen, P. O., Eide, C. A., Ayuda-Duran, P., Potdar, S., Kuusanmaki, H., Andersson, E. I., Mpindi, J. P., Pemovska, T., Kontro, M., Heckman, C. A., Kallioniemi, O., Wennerberg, K., Hjorth-Hansen, H., Druker, B. J., Enserink, J. M., Tyner, J. W., Mustjoki, S. & Porkka, K., 4 Apr 2017, In : Oncotarget. 8, 14, p. 22606-22615 10 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
El Missiry, M., Hjorth-Hansen, H., Richter, J., Olson-Stromberg, U., Stenke, L., Porkka, K., Kreutzman, A. & Mustjoki, S., 30 Jan 2017, In : PLoS One. 12, 1, 17 p., 0171041.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML
Malani, D., Murumagi, A., Yadav, B., Kontro, M., Eldfors, S., Kumar, A., Karjalainen, R., Majumder, M. M., Ojamies, P., Pemovska, T., Wennerberg, K., Heckman, C., Porkka, K., Wolf, M., Aittokallio, T. & Kallioniemi, O., May 2017, In : Leukemia. 31, 5, p. 1187-1195 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Genomilääketieteen sovelluksia sairauksien hoidossa
Porkka, K., Niemi, M., Leppä, E., Västrik, I., Partanen, J., Ihalainen, J., Jokiranta, S. & Pöllänen, P., 2017, In : Duodecim. 133, 8, p. 782-790 9 p.Research output: Contribution to journal › Article › Professional
Open Access
File
High Amount of PD1+TIM3+ T Helper Cells May Predict Poor Outcome in Adult Acute Lymphoblastic Leukemia
Hohtari, H., Bruck, O., Blom, S., Turkki, R., Ribeiro, A., Sinisalo, M., Kovanen, P., Kallioniemi, O., Pellinen, T., Porkka, K. & Mustjoki, S., 2017, p. 3985. 1 p.Research output: Conference materials › Abstract › Research › peer-review
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
Kontro, M., Kumar, A., Majumder, M. M., Eldfors, S., Parsons, A., Pemovska, T., Saarela, J. S., Yadav, B., Malani, D. R., Fløisand, Y., Höglund, M., Remes, K., Gjertsen, B-T., Kallioniemi, O-P., Wennerberg, J. K., Heckman, C. A. & Porkka, K. V. K., 2017, In : Leukemia. 31, 2, p. 301-309 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
File
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
Eldfors, S., Kuusanmäki, H., Kontro, M., Majumder, M. M., Parsons, A., Edgren, H., Pemovska, T., Kallioniemi, O., Wennerberg, K., Gökbuget, N., Burmeister, T., Porkka, K. & Heckman, C. A., 2017, In : Leukemia. 31, 1, p. 51-57 7 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing
Majumder, M. M., Silvennoinen, R., Anttila, P., Tamborero, D., Eldfors, S., Yadav, B., Karjalainen, R., Kuusanmaki, H., Lievonen, J., Parsons, A., Suvela, M., Jantunen, E., Porkka, K. & Heckman, C. A., 22 Aug 2017, In : Oncotarget. 8, 34, p. 56338-56350 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
IMMUNOLOGICAL CHARACTERIZATION OF PH plus ALL BONE MARROW BY MULTIPLEX IMMUNOHISTOCHEMISTRY
Hohtari, H., Bruck, O., Blom, S., Turkki, R., Ribeiro, A., Sinisalo, M., Kovanen, P., Kallioniemi, O., Pellinen, T., Porkka, K. & Mustjoki, S., 26 Jun 2017, In : Haematologica. 102, p. 654-654 1 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Ilander, M., Olsson-Stromberg, U., Schlums, H., Guilhot, J., Bruck, O., Lahteenmaki, H., Kasanen, T., Koskenvesa, P., Soderlund, S., Hoglund, M., Markevarn, B., Sjalander, A., Lotfi, K., Dreimane, A., Lubking, A., Holm, E., Bjoreman, M., Lehmann, S., Stenke, L., Ohm, L. & 11 others, May 2017, In : Leukemia. 31, 5, p. 1108-1116 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML
Karjalainen, R., Pemovska, T., Popa, M., Liu, M., Javarappa, K. K., Majumder, M. M., Yadav, B., Tamborero, D., Tang, J., Bychkov, D., Kontro, M., Parsons, A., Suvela, M., Safont, M. M., Porkka, K., Aittokallio, T., Kallioniemi, O., McCormack, E., Gjertsen, B. T., Wennerberg, K. & 2 others, 10 Aug 2017, In : Blood. 130, 6, p. 789-802 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
LOW IL-2 CONCENTRATION FAVORS GENERATION OF EARLY MEMORY T CELLS OVER TERMINAL EEFECTORS DURING CAR T-CELL EXPANSION
Luostarinen, A., Kaartinen, T., Maliniernii, P., Keto, J., Arvas, M., Belt, H., Koponen, J., Loskog, A., Mustjoki, S., Porkka, K., Yla-Herttuala, S. & Korhonen, M., May 2017, In : Cytotherapy. 19, 5, p. S8-S8 1 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion
Kaartinen, T., Luostarinen, A., Maliniemi, P., Keto, J., Arvas, M., Belt, H., Koponen, J., Loskog, A., Mustjoki, S., Porkka, K., Yla-Herttuala, S. & Korhonen, M., Jun 2017, In : Cytotherapy. 19, 6, p. 689-702 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia
Ojamies, P., Kontro, M., Edgren, H., Ellonen, P., Lagström, S., Almusa, H., Miettinen, T., Eldfors, S., Tamborero, D., Wennerberg, K., Heckman, C., Porkka, K., Wolf, M. & Kallioniemi, O., 2017, In : Leukemia. 31, 5, p. 1048-1058 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib
Sopper, S., Mustjoki, S., Gjertsen, B. T., Giles, F., Hochhaus, A., Janssen, J. J. W. M., Porkka, K. & Wolf, D., Oct 2017, In : Leukemia. 31, 10, p. 2264-2267 5 p.Research output: Contribution to journal › Article › Scientific
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia
Sopper, S., Mustjoki, S., White, D., Hughes, T., Valent, P., Burchert, A., Gjertsen, B. T., Gastl, G., Baldauf, M., Trajanoski, Z., Giles, F., Hochhaus, A., Ernst, T., Schenk, T., Janssen, J. J. W. M., Ossenkoppele, G. J., Porkka, K. & Wolf, D., 10 Jan 2017, In : Journal of Clinical Oncology. 35, 2, p. 175-+ 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
Gullaksen, S-E., Skavland, J., Gavasso, S., Tosevski, V., Warzocha, K., Dumrese, C., Ferrant, A., Gedde-Dahl, T., Hellmann, A., Janssen, J., Labar, B., Lang, A., Majeed, W., Mihaylov, G., Stentoft, J., Stenke, L., Thaler, J., Thielen, N., Verhoef, G., Voglova, J. & 9 others, Aug 2017, In : Haematologica. 102, 8, p. 1361-1367 7 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis
Savola, P., Kelkka, T., Rajala, H. L., Kuuliala, A., Kuuliala, K., Eldfors, S., Ellonen, P., Lagstrom, S., Lepisto, M., Hannunen, T., Andersson, E. I., Khajuria, R. K., Jaatinen, T., Koivuniemi, R., Repo, H., Saarela, J., Porkka, K., Leirisalo-Repo, M. & Mustjoki, S., 21 Jun 2017, In : Nature Communications. 8, 14 p., 15869.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
2016
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia
El Missiry, M., Awad, S. A., Koskela, H. L. M., Al-Samadi, A., Ekblom, M., Markevan, B., Astrand-Grundstrom, I., Wold, M., Svedahl, E. R., Juhl, B. R., Bjerrum, O. W., Haulin, I., Porkka, K., Olsson-Stromberg, U., Hjorth-Hansen, H. & Mustjoki, S., May 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 5, p. 1041-1050 10 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
ASSESSMENT OF THERAPY RESPONSE IN CHRONIC MYELOID LEUKEMIA VIA 1 MONTH BCR-ABL1 TRANSCRIPT DECLINE
El Missiry, M., Hjorth-hansen, H., Richter, J., Olson-Stromberg, U., Stenke, L., Porkka, K., Kreutzmann, A. & Mustjoki, S., Jun 2016, In : Haematologica. 101, p. 63-63 1 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Cessation of Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response: Results of the Euro-Ski Trial
Mahon, F., Richter, J., Guilhot, J., Hjorth-Hansen, H., Almeida, A., Janssen, J. J. W. M., Mayer, J., Porkka, K., Panayiotidis, P., Stromberg, U., Berger, M. G., Diamond, J., Ehrencrona, H., Kairisto, V., Polakova, K. M., Mueller, M. C., Mustjoki, S., Hochhaus, A., Pfirrmann, M. & Saussele, S., 2 Dec 2016, In : Blood. 128, 22, 4 p., 787 .Research output: Contribution to journal › Meeting Abstract › Research › peer-review
CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism
Pietarinen, P., Koskenvesa, P., Klievink, J., Porkka, K., Niemi, M. & Mustjoki, S., 2 Dec 2016, In : Blood. 128, 22, 4 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Deregulated CD62L expression predicts molecular response to nilotinib therapy in early chronic phase Chronic Myelogenous Leukemia (CML-CP)
Wolf, D., Mustjoki, S., Gjertsen, B. -T., Gastl, G., Baldauf, M., Trajanoski, Z., Giles, F., Hochhaus, A., Ernst, T., Schenk, T., Janssen, J., Porkka, K. & Sopper, S., Oct 2016, In : Oncology research and treatment. 39, p. 39-39 1 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
Roboz, G. J., Montesinos, P., Selleslag, D., Wei, A., Jang, J-H., Falantes, J., Voso, M. T., Sayar, H., Porkka, K., Marlton, P., Almeida, A., Mohan, S., Ravandi, F., Garcia-Manero, G., Skikne, B. & Kantarjian, H., 2016, In : Future Oncology. 12, 3, p. 293-302 10 p.Research output: Contribution to journal › Article › Scientific › peer-review
Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia
Hohtari, H., Sinisalo, M., Nousiainen, T., Koskenvesa, P., Wartiovaara-Kautto, U., Mustjoki, S., Koistinen, P., Saeily, M., Itaelae-Remes, M., Elonen, E., Remes, K. & Porkka, K., 2 Dec 2016, In : Blood. 128, 22, 5 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Effects of Dasatinib and Interferon-alpha Combination Treatment on the Immune System in CML
Ilander, M., Lahteenmaki, H., Olsson-Stromberg, U., Stentoft, J., Richter, J., Koskenvesa, P., Hoglund, M., Dreimane, A., Porkka, K., Gedde-Dahl, T., Gjertsen, B. T., Gruber, F. X., Stenke, L., Myhr-Eriksson, K., Markevarn, B., Lubking, A., Vestergaard, H., Udby, L., Bjerrum, O. W., Hjorth-Hansen, H. & 1 others, 2 Dec 2016, In : Blood. 128, 22, 5 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland
Trotta, L., Hautala, T., Hamalainen, S., Syrjanen, J., Viskari, H., Almusa, H., Lepisto, M., Kaustio, M., Porkka, K., Palotie, A., Seppanen, M. & Saarela, J., Oct 2016, In : European Journal of Human Genetics. 24, 10, p. 1473-1478 6 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Steegmann, J. L., Baccarani, M., Breccia, M., Casado, L. F., Garcia-Gutierrez, V., Hochhaus, A., Kim, D-W., Kim, T. D., Khoury, H. J., Le Coutre, P., Mayer, J., Milojkovic, D., Porkka, K., Rea, D., Rosti, G., Saussele, S., Hehlmann, R. & Clark, R. E., Aug 2016, In : Leukemia. 30, 8, p. 1648-1671 24 p.Research output: Contribution to journal › Review Article › Scientific › peer-review
Open Access
File
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study
Hochhaus, A., Rosti, G., Cross, N. C. P., Steegmann, J. L., le Coutre, P., Ossenkoppele, G., Petrov, L., Masszi, T., Hellmann, A., Griskevicius, L., Wiktor-Jedrzejczak, W., Rea, D., Coriu, D., Bruemmendorf, T. H., Porkka, K., Saglio, G., Gastl, G., Mueller, M. C., Schuld, P., Di Matteo, P. & 5 others, Jan 2016, In : Leukemia. 30, 1, p. 57-64 8 p.Research output: Contribution to journal › Article › Scientific › peer-review
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Agerstam, H., Hansen, N., von Palffy, S., Sanden, C., Reckzeh, K., Karlsson, C., Lilljebjorn, H., Landberg, N., Askmyr, M., Hogberg, C., Rissler, M., Porkka, K., Wadenvik, H., Mustjoki, S., Richter, J., Jaras, M. & Fioretos, T., 8 Dec 2016, In : Blood. 128, 23, p. 2683-2693 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
IL1RAP Antibodies Block IL1-Induced Expansion of Primitive CML Cells and Display Therapeutic Effects in Xenograft Models
Agerstam, H., Hansen, N., Von Palffy, S., Sanden, C., Reckzeh, K., Karlsson, C., Lilljebjorn, H., Landberg, N., Askmyr, M., Hogberg, C., Rissler, M., Porkka, K., Wadenvik, H., Mustjoki, S., Richter, J., Jaras, M. & Fioretos, T., 2 Dec 2016, In : Blood. 128, 22, 4 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Impact of starting material and expansion conditions on cell yield and composition of CAR T cell products
Kaartinen, T., Luostarinen, A., Belt, H., Koponen, J., Nousiainen, A., Mäkinen, P., Yla-Herttuala, S., Mustjoki, S., Porkka, K. & Korhonen, M., May 2016, In : Scandinavian Journal of Immunology. 83, 5, p. 374-374 1 p.Research output: Contribution to journal › Meeting Abstract › Research › peer-review
Intrinsic resistance to PIM kinase inhibition in AML through p38a-mediated feedback activation of mTOR signaling
Brunen, D., Jose Garcia-Barchino, M., Malani, D., Basheer, N. J., Lieftink, C., Beijersbergen, R. L., Murumagi, A., Porkka, K., Wolf, M., Zwaan, C. M., Fornerod, M., Kallioniemi, O., Angel Martinez-Climent, J. & Bernards, R., 21 Jun 2016, In : Oncotarget. 7, 25, p. 37407-37419 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy
Thielen, N., Richter, J., Baldauf, M., Barbany, G., Fioretos, T., Giles, F., Gjertsen, B-T., Hochhaus, A., Schuurhuis, G. J., Sopper, S., Stenke, L., Thunberg, S., Wolf, D., Ossenkoppele, G., Porkka, K., Janssen, J. & Mustjoki, S., 15 Aug 2016, In : Clinical Cancer Research. 22, 16, p. 4030-4038 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity
Schiffer, C. A., Cortes, J. E., Hochhaus, A., Saglio, G., le Coutre, P., Porkka, K., Mustjoki, S., Mohamed, H. & Shah, N. P., 1 May 2016, In : Cancer. 122, 9, p. 1398-1407 10 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File